Jaguar Animal Health Inc (JAGX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.85
• Market Cap: $3.63M
• EPS: $-2.58
• 52-Week High: $15.75
• 52-Week Low: $0.56

Market Sentiment

Jaguar Animal Health Inc currently has a Neutral sentiment score of -0.02.

About Jaguar Animal Health Inc

Jaguar Animal Health, Inc. (JAGX) is a commercial-stage biopharmaceutical company headquartered in San Francisco, focused on developing innovative prescription therapies for both human and animal health, with a primary emphasis on chronic gastrointestinal disorders and debilitating diarrhea. Utilizing proprietary technologies rooted in extensive research of the gastrointestinal microbiome, Jaguar Health is committed to delivering effective and sustainable healthcare solutions that enhance the...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Jaguar Animal Health Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does JAGX pay dividends?

Jaguar Animal Health Inc (JAGX) does not currently pay a regular dividend.

What is JAGX's market cap?

Jaguar Animal Health Inc (JAGX) has a market capitalization of $3.63M with a current stock price of $0.85.